Although tobacco use is declining in the US, the use of other drugs such as marijuana is on the rise. Behavioral Diagnostics Inc. uses their years of experience in genetic research to help identify, manage, and even prevent substance abuse. Dr. Philibert and Dr. Madan founded the company in 2009 based on the idea of commercializing their research, which showed that substance use and abuse leads to specific recognizable genetic chemical changes. Their vision is that by fully understanding how different substances alter someone’s genetic profile, they can increase the quality of treatment for substance abuse problems, as well as definitively detect substance use when appropriate. 

Venture Information
Stage: 
Pre-Clinical
Market: 
Substance Use Diagnostics
Company Information
Founders: 
Rob Philibert, M.D., Ph.D.
Anup Madan, Ph.D.